In one woman with recurrent acute pancreatitis, hypertriglyceridemia and type 2 diabetes, semaglutide was identified as a possible contributor and was switched to dapagliflozin after recurrence.
In plain wordsIn one woman with repeated pancreatitis, semaglutide was named as a possible contributor and was replaced by another diabetes drug.
- Peptide
- Semaglutide
- Outcome
- Not applicablePossible contribution to recurrent acute pancreatitis
- Study
n = 1
- Outcome group
- Adverse events · Gastrointestinal
- Studied dose
- Dose not stated
Source sentences
Medication-related risks, such as semaglutide, were also identified as possible contributors.
2 context sentences(design, population, supporting numbers)
After the recurrence of pancreatitis, her T2DM treatment was changed from semaglutide to dapagliflozin.
This case report presents a 30-year-old Asian woman whose episodes of pancreatitis were complicated by hypertriglyceridemia, Type 2 diabetes mellitus (T2DM), and occasional alcohol use.